Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations by Höglander, EK, Nord, S, Wedge, DC, Lingjærde, OC, Silwal-Pandit, L, Gythfeldt, HV, Vollan, HKM, Fleischer, T, Krohn, M, Schlitchting, E, Borgen, E, Garred, Ø, Holmen, MM, Wist, E, Naume, B, Van Loo, P, Børresen-Dale, A-L, Engebraaten, O, Kristensen, V